Inaktiver Wert

Power3 Medical Products, Inc. Aktie

Aktien

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

Power3 Medical Products, Inc. : Amarantus BioSciences Licenses Parkinson's Disease Diagnostic Biomarker Test from Power3 Medical Products	23.01.12
POWER 3 MED PROD : Power3 Medical to Publish Medical Breakthrough Documented During Clinical Trials of Power3 Medical's Flag Ship NuroPro® Diagnostic	20.05.10
POWER 3 MED PROD : Power3 Medical Announces Filing of Two Provisional Patent Applications with the USPTO	14.05.10
POWER 3 MED PROD : Power3 Presents State of the Company Report at the Economic Development Partners Luncheon	12.05.10
POWER 3 MED PROD : Power3's Dr. Ira L. Goldknopf Stated in an Interview That the Company Plans to Completely and Strategically Reposition Itself Through a Consolidation of Stem Cell, Diagnostic, and Therapeutic Companies and Intellectual Property	07.05.10

Manager	Titel	Alter	Seit
Helen R. Park CEO	Chief Executive Officer	87	07.09.08
Ira L. Goldknopf CHM	Chairman	76	01.05.04

Aufsichtsräte	Titel	Alter	Seit
Ira L. Goldknopf CHM	Chairman	76	01.05.04
Helen R. Park CEO	Chief Executive Officer	87	07.09.08

Sektor

	% 1. Jan.	Kap.
MODERNA, INC.	+26.37%	44.96 Mrd.
IQVIA HOLDINGS INC.	-1.01%	42.65 Mrd.
LONZA GROUP AG	+46.00%	41.85 Mrd.
CELLTRION, INC.	-5.31%	29.04 Mrd.
ICON PUBLIC LIMITED COMPANY	+9.34%	26.08 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-21.69%	19.03 Mrd.
BIO-TECHNE CORPORATION	+6.23%	12.75 Mrd.
MEDPACE HOLDINGS, INC.	+26.99%	12.06 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.38%	11.75 Mrd.